Cellectis S.A. (CLLS)

Cellectis Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-101.06	-106.14	-114.2	-81.07	-102.09
Depreciation & Amortization	18.52	18.44	14.16	7.83	6.88
Share-Based Compensation	5.23	6.04	11.49	10.03	26.88
Other Operating Activities	52.56	-5.78	-16.01	-17.05	-0.81
Operating Cash Flow	-24.75	-87.44	-104.56	-80.26	-69.14
Capital Expenditures	-1.07	-2.43	-18.54	-44.08	-12.5
Acquisitions	-1.64	0	0	0	0
Change in Investments	-12.87	0.13	14.86	2.88	-23.33
Other Investing Activities	0.08	-0.46	10.97	-13.15	-0.05
Investing Cash Flow	-15.51	-2.76	7.28	-54.34	-35.87
Share Issuance / Repurchase	67.94	-0.57	44.64	0	0
Debt Issued / Paid	13.15	-6.94	-11.01	19.4	-3.39
Other Financing Activities	1.78	8.65	13.9	7.92	-0.47
Financing Cash Flow	82.87	1.15	47.53	27.32	-3.86
Exchange Rate Effect	0.88	-3.36	-5.75	7.91	-2.1
Net Cash Flow	42.61	-89.06	-49.76	-107.28	-108.88
Free Cash Flow	-25.82	-89.88	-123.11	-124.34	-81.64
Free Cash Flow Margin	-280.85%	-349.37%	-318.95%	-208.75%	-355.12%
Free Cash Flow Per Share	-0.45	-1.97	-2.75	-2.93	-1.92

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).